We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
AALR3.SA

Price
5.00
Stock movement up
+0.07 (1.42%)
Company name
Centro de Imagem Diagnósticos S.A
Exchange
(SA
,
Currency
BRL
)
Sector
Healthcare >
Diagnostics & Research
Market cap
591.01M
Ent value
1.87B
Price/Sales
0.49
Price/Book
0.50
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-49.75%
3 year return
-36.61%
5 year return
-17.80%
10 year return
-
Last updated: 2025-06-22

DIVIDENDS

AALR3.SA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF4.64
Price to FCF17.02
Price to EBITDA4.20
EV to EBITDA13.32

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales0.49
Price to Book0.50
EV to Sales1.56

FINANCIALS

Per share

Loading...
Per share data
Current share count118.20M
EPS (TTM)-1.39
FCF per share (TTM)0.29

Income statement

Loading...
Income statement data
Revenue (TTM)1.20B
Gross profit (TTM)363.96M
Operating income (TTM)69.35M
Net income (TTM)-164.87M
EPS (TTM)-1.39
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)30.22%
Operating margin (TTM)5.76%
Profit margin (TTM)-13.69%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash167.70M
Net receivables0.00
Total current assets480.30M
Goodwill844.77M
Intangible assets159.77M
Property, plant and equipment0.00
Total assets2.64B
Accounts payable114.70M
Short/Current long term debt975.06M
Total current liabilities625.42M
Total liabilities1.45B
Shareholder's equity1.18B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)127.30M
Capital expenditures (TTM)92.58M
Free cash flow (TTM)34.72M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-13.91%
Return on Assets-6.25%
Return on Invested Capital-11.43%
Cash Return on Invested Capital2.41%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.87
Daily high5.00
Daily low4.79
Daily Volume32K
All-time high24.30
1y analyst estimate20.50
Beta1.03
EPS (TTM)-1.39
Dividend per share-
Ex-div date27 Apr 2020
Next earnings date6 Aug 2025

Downside potential

Loading...
Downside potential data
AALR3.SAS&P500
Current price drop from All-time high-79.42%-3.04%
Highest price drop-80.66%-56.47%
Date of highest drop10 Jun 20259 Mar 2009
Avg drop from high-32.08%-11.04%
Avg time to new high58 days12 days
Max time to new high838 days1805 days
COMPANY DETAILS
AALR3.SA (Centro de Imagem Diagnósticos S.A) company logo
Marketcap
591.01M
Marketcap category
Small-cap
Description
Alliança Saúde e Participações S.A. provides diagnostic medicine services in Brazil. It offers imaging diagnosis and graphic methods; nuclear medicine cytology; pathological anatomy; human vaccination and immunization; medical activity; and clinical analysis, as well as other auxiliary diagnostic support services. The company also engages in the import of medical and hospital equipment, diagnostic sets, and related items; provision of consultancy, advice, courses, and lectures in the health area; managing chronic diseases; research and development in the area of diagnostic medicine; preparation, editing, publication, and distribution of newspapers, books, magazines, periodicals, and other written communication vehicles intended for scientific dissemination; and granting and administration of business franchises. The company was formerly known as Centro de Imagem Diagnósticos S.A. and changed its name to Alliança Saúde e Participações S.A. in April 2023. Alliança Saúde e Participações S.A. was founded in 1992 and is headquartered in São Paulo, Brazil.
Employees
0
Investor relations
-
CEO
Country
Brazil
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found